• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Methylprednisolone May Be Superior to Dexamethasone in COVID-19: A Meta-Analysis of Randomized Controlled Trials.

作者信息

Beran Azizullah, Ayesh Hazem, Mhanna Mohammed, Srour Omar, Musallam Rami, Sayeh Wasef, Khokher Waleed, Altorok Nehaya, Noori Zaid, Assaly Ragheb, Altorok Nezam

机构信息

Department of Internal Medicine, University of Toledo, Toledo, OH.

Department of Internal Medicine, St. Vincent Charity Medical Center, Cleveland, OH.

出版信息

Am J Ther. 2022;29(3):e351-e354. doi: 10.1097/MJT.0000000000001507. Epub 2022 Apr 8.

DOI:10.1097/MJT.0000000000001507
PMID:35533325
Abstract
摘要

相似文献

1
Methylprednisolone May Be Superior to Dexamethasone in COVID-19: A Meta-Analysis of Randomized Controlled Trials.在新冠疫情中，甲泼尼龙可能优于地塞米松：一项随机对照试验的荟萃分析。
Am J Ther. 2022;29(3):e351-e354. doi: 10.1097/MJT.0000000000001507. Epub 2022 Apr 8.
2
Methylprednisolone or dexamethasone? How should we choose to respond to COVID-19?: A systematic review and meta-analysis of randomized controlled trials.甲泼尼龙还是地塞米松？我们应该如何选择应对 COVID-19？：一项随机对照试验的系统评价和荟萃分析。
Medicine (Baltimore). 2023 Sep 8;102(36):e34738. doi: 10.1097/MD.0000000000034738.
3
Methylprednisolone Versus Dexamethasone in COVID-19: A Meta-Analysis of Nonrandomized Studies.甲基强的松龙与地塞米松治疗新冠肺炎的疗效比较：非随机研究的荟萃分析
Am J Ther. 2022;29(3):e354-e357. doi: 10.1097/MJT.0000000000001506. Epub 2022 Apr 11.
4
A Comparison of Methylprednisolone and Dexamethasone in Intensive Care Patients With COVID-19.COVID-19 重症监护患者中甲基强的松龙与地塞米松的比较。
J Intensive Care Med. 2021 Jun;36(6):673-680. doi: 10.1177/0885066621994057. Epub 2021 Feb 25.
5
A Comparison of the Efficacy of Adjuvant Parenteral Methylprednisolone and Dexamethasone in Reducing Covid-19 Disease Severity and Mortality among the Moderate to Critical Patients -A Retrospective Study.辅助性肌内注射甲泼尼龙和地塞米松治疗中重度至危重症 COVID-19 患者的疗效比较：一项回顾性研究。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
6
Dexamethasone for COVID-19: data needed from randomised clinical trials in Africa.用于治疗新冠肺炎的地塞米松：非洲随机临床试验所需数据。
Lancet Glob Health. 2020 Sep;8(9):e1125-e1126. doi: 10.1016/S2214-109X(20)30318-1. Epub 2020 Jul 14.
7
[In patients hospitalized for COVID-19, does dexamethasone reduce 28-days mortality compared to standard treatment?].[对于因新冠肺炎住院的患者，与标准治疗相比，地塞米松是否能降低28天死亡率？]
Rev Med Interne. 2020 Nov;41(11):790-791. doi: 10.1016/j.revmed.2020.08.005. Epub 2020 Oct 9.
8
Dexamethasone in the management of covid -19.地塞米松在新冠病毒病治疗中的应用
BMJ. 2020 Jul 3;370:m2648. doi: 10.1136/bmj.m2648.
9
Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.COVID-19 肺炎的糖皮质激素（CORTIVID）治疗：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):43. doi: 10.1186/s13063-020-04999-4.
10
Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients: An updated network meta-analysis of 48 randomized controlled trials.比较 COVID-19 重症患者药物干预措施的疗效和安全性：48 项随机对照试验的更新网络荟萃分析。
Medicine (Baltimore). 2022 Oct 14;101(41):e30998. doi: 10.1097/MD.0000000000030998.

引用本文的文献

1
Evaluating the Risk-Benefit Profile of Corticosteroid Therapy for COVID-19 Patients: A Scoping Review.评估COVID-19患者皮质类固醇治疗的风险效益概况：一项范围综述。
Pharmacy (Basel). 2024 Aug 22;12(4):129. doi: 10.3390/pharmacy12040129.
2
Comparative Efficacy of High-Dose Dexamethasone Versus Methylprednisolone in Coronavirus Disease 2019 (COVID-19)-Associated Acute Respiratory Distress Syndrome.高剂量地塞米松与甲泼尼龙治疗2019冠状病毒病（COVID-19）相关急性呼吸窘迫综合征的疗效比较
Cureus. 2024 Mar 7;16(3):e55725. doi: 10.7759/cureus.55725. eCollection 2024 Mar.
3
Methylprednisolone or dexamethasone? How should we choose to respond to COVID-19?: A systematic review and meta-analysis of randomized controlled trials.
甲泼尼龙还是地塞米松？我们应该如何选择应对 COVID-19？：一项随机对照试验的系统评价和荟萃分析。
Medicine (Baltimore). 2023 Sep 8;102(36):e34738. doi: 10.1097/MD.0000000000034738.
4
A systematic review and meta-analysis of glucocorticoids treatment in severe COVID-19: methylprednisolone versus dexamethasone.糖皮质激素治疗重症 COVID-19 的系统评价和荟萃分析：甲泼尼龙与地塞米松。
BMC Infect Dis. 2023 May 5;23(1):290. doi: 10.1186/s12879-023-08280-2.